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The tumor microenvironment is a dynamic landscape in which the physical and
mechanical properties evolve dramatically throughout cancer progression. These
changes are driven by enhanced tumor cell contractility and expansion of the growing
tumor mass, as well as through alterations to the material properties of the surrounding
extracellular matrix (ECM). Consequently, tumor cells are exposed to a number of
different mechanical inputs including cell–cell and cell-ECM tension, compression stress,
interstitial fluid pressure and shear stress. Oncogenes engage signaling pathways that
are activated in response to mechanical stress, thereby reworking the cell’s intrinsic
response to exogenous mechanical stimuli, enhancing intracellular tension via elevated
actomyosin contraction, and influencing ECM stiffness and tissuemorphology. In addition
to altering their intracellular tension and remodeling the microenvironment, cells actively
respond to these mechanical perturbations phenotypically through modification of gene
expression. Herein, we present a description of the physical changes that promote
tumor progression and aggression, discuss their interrelationship and highlight emerging
therapeutic strategies to alleviate the mechanical stresses driving cancer to malignancy.
Keywords: cancer progression, cell contractility, mechanical stresses, tissue tension, solid stress, ECM stiffness,
therapeutic targets
INTRODUCTION
The tumor microenvironment is a dynamic landscape composed of cancer cells surrounded by the
extracellular matrix (ECM) and a host of stromal cells, including fibroblasts, immune cells, blood
and lymphatic vascular cells, and other tissue-specific cells (e.g., adipocytes). From transformation
of the normal tissue, on through progression of the primary tumor to invasion, dissemination, and
metastasis, the physical context of the tumor changes dramatically (Kumar and Weaver, 2009).
These changes to the tumor microenvironment are driven by enhanced tumor cell contractility,
expansion of the growing tumor mass, and alterations to the material properties of the surrounding
ECM. Indeed, the physical properties of a tissue, such as ECM stiffness and architecture, can have a
profound influence on cellular behavior and ultimately, tissue organization and function.
Cancer progression is associated with changes to both the cellular responses to chemical and
mechanical signals as well as to the material properties of the ECM components of the transformed
tissue (reviewed in Butcher et al., 2009; Kumar andWeaver, 2009). Cells are exposed to a number of
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different mechanical stresses (Figures 1, 2A) that activate
downstream signaling pathways through a process termed
mechanotransduction. Importantly, oncogenes engage many of
the same signaling pathways that are activated in response to
mechanical stress (reviewed in Yu et al., 2011), thereby reworking
the cell’s intrinsic response to exogenous mechanical stimuli
and enhancing cytoskeletal contractility. Active tumor cell
engagement with this mechanically-evolving microenvironment
results in changes to cytoskeletal structure, cellular shape,
differentiation, survival/death, proliferation, adhesion, and
migration which can drive tumor progression and aggression
(Butcher et al., 2009; Yu et al., 2011). Herein we present
a description of the mechanical stresses that promote tumor
progression and aggression, discuss their interrelationship,
and highlight emerging therapeutic strategies to alleviate the
mechanical stresses driving cancer to malignancy.
TUMOR CELL CONTRACTILITY
Cells respond to mechanical stresses by altering their
intracellular tension (Figure 2). This response is achieved
through coordinated cytoskeletal rearrangement and actomyosin
contraction. Mechanotransduction is the process through
which cells sense and respond to mechanical signals (e.g., ECM
rigidity, compression, tension) by translating these mechanical
stimuli into biochemical signals. Cellular interpretation of these
biochemical signals influences cell morphology, behavior and
function.
Mechanotransduction and Actomyosin
Contractility
Mechanotransduction is essential for a number of normal
biological processes, such as hearing (reviewed in Schwander
et al., 2010), and pathologies, such as cancer. Focal adhesion and
adherens junction protein complexes mediate the bi-directional
physical communication between cell-ECM and neighboring
cells, respectively. In this way, ECM rigidity and intercellular
dynamics modify intracellular tension, which feeds back to
influence tissue stiffness and morphology. Application of forces
to the cell membrane can also lead to opening of mechanically-
activated ion channels (e.g., Piezo1 and Piezo2) and actomyosin
contractility (Maroto et al., 2012, reviewed inHonore et al., 2015).
Cells interact with the ECM via integrin receptors and, in
response to mechanical signals from the ECM, integrins become
activated and oligomerized (Butcher et al., 2009). Subsequently,
the adhesion plaque protein talin undergoes a conformational
change, which fosters intermolecular interactions. Once the
integrin-adhesion plaque association has been activated, the
focal complexes begin to assemble and eventually mature into
focal adhesions (Butcher et al., 2009). Focal adhesions are
composed of multiple mechanosensors (e.g., talin, vinculin),
signaling molecules [e.g., focal adhesion kinase (FAK), SRC,
phosphatidylinositol-3 kinase (PI3K)], adapter proteins (e.g.,
paxillin) and actin linker proteins (e.g., filamin, alpha-actinin)
which physically connect the integrins to the cytoskeleton
(reviewed in Wozniak et al., 2004). On stiff substrates, physical
FIGURE 1 | Mechanical stress.
resistance to cellular tension enhances talin stabilization
through vinculin binding and also potentiates FAK activation
(Figure 2B). Focal adhesion formation results in Rho/Rho
kinase (ROCK) activation and actomyosin contraction.
Reinforcement / maturation of the focal adhesion complex
further increases contraction via the assembly of actin stress
fibers (Figure 2B). In addition, via interplay with growth factor
receptors (GFRs) and G-protein coupled receptors (GPCRs),
focal adhesion formation also activates signaling downstream of
both FAK and SRC (e.g., MAPK) (Butcher et al., 2009; Yu et al.,
2011).
The magnitude of these transmitted mechanical signals is
regulated by the stabilization of the focal adhesions (greater
number or size), which leads to augmented actomyosin
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FIGURE 2 | Mechanical forces and cellular contractility. (A) Forces exerted onto a cell can cause three types of mechanical stress: tensile (stretch), compressive, and
shear. Forces that induce tensile and compressive stress are applied perpendicular to the cell surface, while forces causing shear stress are exerted parallel to the cell
surface. (B) Integrin clusters activated through ECM binding are bound by talin, initiating actin polymerization and producing intracellular tension. In response to high
tensile force (a consequence of elevated ECM rigidity), FAK is activated (top). Activation of FAK leads to the recruitment of additional linker proteins, focal adhesion
maturation, and increased actomyosin contraction via the assembled actin stress fibers (bottom).
contractility and traction force generation. Focal adhesion
formation and FAK activation synchronizes the immediate
response (traction force generation) and the sustained response
(altered gene expression) through coordinated actomyosin
contraction and signaling pathway activation, respectively.
Increased cellular tension, integrin signaling and crosstalk with
GFR and GPCR signaling pathways, ultimately lead to enhanced
tumor cell growth, survival, and invasion (Provenzano and Keely,
2011).
Similar to the focal adhesions, the adherens junction
complexes that communicate intercellular tension are composed
of receptors (i.e., cadherins), mechanosensors (i.e., catenins),
linker proteins, and signaling molecules (i.e., SRC). Adherens
junctions and focal adhesion complexes crosstalk though
shared protein components and physical interconnection via
the actin cytoskeleton (Oldenburg et al., 2015, reviewed in
Mui et al., 2016). Indeed, actomyosin contractility-induced cell
tension can promote tissue stiffness and β-catenin mediated
interfollicular epidermal hyperplasia and tumor growth
(Samuel et al., 2011).
In addition, mechanotransduction can occur through
mechanically-activated ion channels (e.g., Piezo1), which
respond to external stimuli either directly or indirectly.
Mechanically-activated ion channels, which are regulated
by GTPases, were among the first mechanosensor proteins
described. Like other chemical mechanotransduction pathways,
signals are amplified within the cell and crosstalk with other
signaling pathways. These proteins regulate many cellular
processes, such as cell polarity (Huang et al., 2015) and
proliferation (Basson et al., 2015) that are perturbed in cancer.
Recently, Gudipaty and colleagues demonstrated that stretch-
induced epithelial cell division and extrusion require activation
of Piezo1 (Gudipaty et al., 2017). Mechanically-activated ion
channels, including Piezo1, have been shown to be dysregulated
in both solid (Maroto et al., 2012; McHugh et al., 2012; Yang et al.,
2014; Fels et al., 2016) and non-solid tumors (Morachevskaya
et al., 2007; Nam et al., 2007; Pottosin et al., 2015), implicating
this mode of mechanotransduction as a potential driver of tumor
progression.
Reciprocity of Intracellular Tension and
Gene Expression
Sustained cellular responses to mechanical stimuli depend
ultimately upon altering gene expression. For example,
expression of integrins, matrix metalloproteases (MMP), and
ECM proteins is increased in response to stiff substrates
(Delcommenne and Streuli, 1995; Nukuda et al., 2015). These
gene expression changes enable cells to modify the compliance of
their microenvironment by remodeling the ECM via increased
tension and altered matrix composition and arrangement. Force-
induced gene expression changes can also affect the mechanical
properties of the tumor cell themselves by altering the expression
of cytoskeletal proteins (McGrail et al., 2015).
The magnitude of intracellular tension generated by
actomyosin contractility also depends on the cytoskeletal
composition (type and organization of actin, intermediate
filament and microtubule proteins), which reflects the cell type
and phenotypic state of the cell (Butcher et al., 2009; McGrail
et al., 2015). The cytoskeletal architecture, intracellular tension
and force-generating capabilities of transformed cells are notably
changed from the normal epithelium. Intermediate filaments,
which provide mechanical support to the cell, differ in their
expression profile between normal and transformed epithelial
cells (Kumar and Weaver, 2009). Furthermore, epithelial-to-
mesenchymal transformation (EMT), a proposed feature of
highly metastatic tumor cells, is characterized by a switch from
keratin to vimentin intermediate filament expression (reviewed
in Kumar and Weaver, 2009; Wirtz et al., 2011). Changes to the
cellular cytoskeleton, such as during transformation or EMT,
drastically alter the shape and the amount of tension exerted
on neighboring cells and the ECM. EMT results in cells with
increased migration, invasion and dissemination potential (Yu
et al., 2011).
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In addition to mechanical signals being transduced to
the nucleus through chemical mechanotransduction pathways
(mechanosignaling), it is possible that physical signals may be
directly transduced to the nucleus through physical anchoring
of the cytoskeletal networks with the nuclear lamina via the
linker of nucleoskeleton and cytoskeleton (LINC) complex (Crisp
et al., 2006; Wirtz et al., 2011). This paradigm maintains that
as actin is tethered to both the cell membrane as well as the
nuclear membrane, tensional forces can be transmitted to the
nucleus (via the LINC complex), neighboring cells (via adherens
junctions) and the ECM (via focal adhesions). Interestingly, it
was shown in isolated nuclei that the nucleus also responds to
mechanical tension by inducing nuclear stiffening (Guilluy et al.,
2014); however, what role this plays in the regulation of gene
expression is currently unknown.
Oncogene and Growth Factor Modulation
of Cell Contractility
Mechanotransduction pathways crosstalk with other chemical
signal transduction cascades (e.g., GFR and GPCR signaling
pathways) to influence transient responses and persistent cellular
behaviors though modulation of gene expression (Butcher
et al., 2009; Yu et al., 2011). For instance, stimulation of the
thrombin GPCR Par1 causes RhoA/Rap1 mediated activation
of integrin signaling, phosphorylation of FAK and ERK1/2, and
increased glioblastoma cell proliferation (Sayyah et al., 2014). In
invasivemelanoma cells, cytokine signaling-induced activation of
the JAK1/STAT3 pathway leads to increased ROCK-dependent
actomyosin contractility, that feeds back to reinforce STAT3
signaling and promote ECM remodeling by tumor-associated
stromal fibroblasts (Sanz-Moreno et al., 2011). Thus, mechanical
forces collaborate with biochemical signals to modulate cell, and
ultimately, tissue behavior.
Following transformation, a tumor cell’s intrinsic response
to tension is often altered by oncogene engagement with
mechanotransduction components. For example, EGFR-
transformed breast epithelial cells have elevated ERK-Rho
activity and increased myosin-mediated cell contractility (Paszek
et al., 2005). Furthermore, HRAS activation of ROCK drives the
progression of squamous cell carcinoma by inducing actomyosin
contractility, tissue stiffness (through collagen deposition) and
cell proliferation (Samuel et al., 2011). Moreover, the influences
of oncogene expression and growth factor/cytokine stimulation
can converge onto mechanotransduction pathways to alter
tumor progression. In a KRAS-driven murine pancreatic ductal
carcinoma (PDAC) model, loss of TGF-beta signaling leads to
activation of GPCR-mediated JAK/STAT3 pathway signaling and
stimulation of ROCK1, that increases tumor cell contractility,
induces ECM remodeling and localized stiffening, and promotes
focal adhesion maturation to promote tumor progression and
aggression (Laklai et al., 2016). These studies highlight the
common link and between increased actomyosin contractility
of cells within the tumor microenvironment, augmented ECM
stiffness and cancer progression across a variety of solid tumors
from various organs (i.e., breast, skin, and pancreas).
Tension-Regulated Cellular Processes
Drive Tumor Progression
Increased intracellular tension through actomyosin contractility
is sufficient to induce cell proliferation, disrupt cell–cell adherens
junctions and effect ECM remodeling, all of which can promote
loss of tissue polarity, ECM reorganization/stiffening and tumor
cell invasion (Butcher et al., 2009; Yu et al., 2011) (Figure 3).
Transformed cells exert higher traction forces than normal
cells when embedded within a compliant matrix resembling
physiological stiffness conditions (Wang et al., 2000; Paszek et al.,
2005; Butcher et al., 2009). The ability of a cell to invade depends
upon both the magnitude and direction of traction forces (Koch
et al., 2012).
In addition to a cell’s ability to generate traction, metastasis
necessitates that cells are able to squeeze through small openings
in the ECM and between cells of the endothelium (Wirtz
et al., 2011). Cell compliance was demonstrated to be tuned by
the extracellular context, as tumor cells stiffen as they invade
into 3D collagen gels due to increased actomyosin contractility
(Staunton et al., 2016). Thus, it is not surprising that tumor cells
may become more compliant than their normal counterparts
and that the extent of cellular compliance correlates with
metastatic capability (Guck et al., 2005). Interestingly, higher
target cell membrane tension enhances perforin-mediated killing
by cytotoxic CD8+ T cells (Basu et al., 2016), suggesting that
increased compliance of metastatic tumor cells could potentially
enable them to evade immune destruction.
While the current perspective is that cells need to be softer
to enable migration under spatial constraint, a recent study
demonstrated that the nucleus is the greatest impediment to
confined migration, not cortical tension (Mekhdjian et al.,
2017). This finding suggests that the nucleus, not the cortex,
of metastatic tumor cells is softer and that this deformability,
together with the ability to exert higher traction force at the
integrin adhesions, permits metastatic cells to navigate rapidly
through confined stiff spaces. Thus, the ability of cells to
migrate through a dense ECM depends on adhesiveness, nuclear
volume, contractility, and to a lesser extent cortical cell stiffness
(Lautscham et al., 2015). Indeed, the majority of total cell stiffness
comes from the nucleus, which is the largest organelle and almost
an order of magnitude stiffer than the cytoplasm (Dahl et al.,
2004; Tseng et al., 2004). As cells migrate through dense matrices,
the nucleus must deform, which can cause nuclear rupture and
DNA damage to occur (Denais et al., 2016; Raab et al., 2016).
Decreasing nuclear stiffness, through knockdown of lamin A
expression, increases cell motility and ability to migrate through
dense matrices but impairs the survival of tumor cells exposed to
shear stress (Davidson et al., 2014; Mitchell et al., 2015). Thus,
greater nuclear compliance coupled with elevated contractile
forces enables cells to pull themselves through tight spaces with
less risk of nuclear rupture.
Another form of cellular deformation involved in cell
migration that depends on actin cytoskeleton rearrangement is
invadopodia formation. Invadopodia are linked to tumor cell
invasion and metastasis, and augmenting intracellular tension
(using the PP1/2 inhibitor calyculin A) increases invadopodia
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formation, protease secretion, ECM degradation and an invasive
cellular phenotype (Aung et al., 2014; Jerrell and Parekh, 2014).
Thus cellular tension generation plays important roles in tumor
metastasis.
MICROENVIRONMENTAL STRESSES
Solid Stress
Unchecked proliferation of cancer cells results in rapid expansion
of the tumor mass, compression of the tumor interior and
distention of the surrounding stromal tissue. The forces exerted
by the expanding tumor mass and the resistance to deformation
of the surrounding stromal tissue make up what is collectively
known as solid stress (reviewed in Jain et al., 2014; Figure 3).
Recently, several new methods have been developed to measure
solid stress in tumors which have demonstrated that the tumor
type, tumor size and the properties of the surrounding tissue all
influence tumor solid stress (Nia et al., 2016).
Forces and strains propagated outward from the tumor,
toward the surrounding stromal tissue, can result in increased
ECM tension and remodeling, as well as disruption of tissue
structure surrounding the tumor mass (Jain et al., 2014). Elevated
ECM tension in these adjacent tissues may be exacerbated
by crowding from tumor-associated myofibroblast proliferation
and immune cell infiltration/expansion during the desmoplastic
and pro-inflammatory stromal responses. Furthermore, changes
to the material properties of the ECM (i.e., stiffening due to
deposition/remodeling) can also contribute to the growth and
solid stress of the tumor. Collagen fibers stiffen under tension
causing resistance to further stretching, while hyaluronan can
trap interstitial fluid and swell due to hydration, providing
resistance to compression and increased intratumoral solid stress
(Jain et al., 2014). In order for a tumor to continue to increase in
size, it must displace or degrade the surrounding non-malignant
tissue. Computational modeling has found that the stiffness of a
solid tumor must exceed 1.5 times that of the surrounding tissue
in order to continue to expand (Voutouri et al., 2014).
Conversely, externally-applied forces resulting in compression
or confinement of the tumor volume may reduce cancer
cell proliferation, induce apoptosis/necrosis, augment ECM
deposition/organization, and enhance the invasive andmetastatic
potential of tumor cells (Yu et al., 2011). Indeed, externally-
applied compressive stress is sufficient to reduce the volume
and proliferative rate of cells in the core of multicellular
structures grown in 3Dmatrices (Helmlinger et al., 1997; Delarue
et al., 2014; Mascheroni et al., 2016). Low-proliferating cell
populations contribute to treatment resistance and compression
of tumor cells themselves may compromise the efficacy of
chemotherapeutic agents (Mascheroni et al., 2017). In vivo, 1
month of induced compression stress (at levels comparable to
those measured in growing tumors), leads to translocation of β-
catenin from the adherens junctions to the nucleus, activation
of β-catenin target genes, and increased colon crypt size (due
to hyperplasia) (Fernández-Sánchez et al., 2015), implicating
compression stress as an inducer of tumorigenesis.
Moreover, solid stress compresses blood vessels in the tumor
interior, which impairs the oxygen and nutrient supply to the
tumor and temporarily impedes cancer progression (Padera
et al., 2004). Sustained compression of the vasculature within
the tumor results in poor tissue perfusion, hypoxia and the
development of a necrotic core (Stylianopoulos et al., 2013).
Hypoxia in the tumor core drives metastasis directly by
increasing EMT and stem-like features in cancer cells (reviewed
in Muz et al., 2015), as well as indirectly, through recruitment
of pro-tumor macrophages (reviewed in Condeelis and Pollard,
2006). Together, this increases the invasive and metastatic
potential of tumor cells.
Solid stresses at the periphery of the tumor are sufficient
to cause compression of blood vessels surrounding the tumor
and consequently, vessels in the surrounding normal tissue
are deformed to elliptical shapes (Stylianopoulos et al., 2013).
Constriction of the lymphatic vasculature within the stroma
reduces drainage of extravasated fluid (Jain et al., 2014). Thus,
solid stress may promote elevated interstitial fluid pressure as
a consequence of reduced interstitial space and compromised
collection of fluid due to blocked vessels. In the context of a
confined tumor, such as glioblastoma multiforme (GBM), this
stress may be intensified by confinement of the brain by the skull.
Together, reduced blood flow and increased interstitial pressure
hinders efficient drug delivery of chemotherapeutics to the tumor
and exacerbates hypoxia (Zhang et al., 2014), which reduces the
efficacy of radiation treatment (Mpekris et al., 2015).
Mathematical modeling predicts that changes in the collective
tension (a product of cell–cell adhesion) at the tumor-
stoma interface can affect the shape of the tumor and this
loss of tension can promote collective cell migration and
metastasis (Katira et al., 2013). Thus, rate and direction of
tumor cell migration may also be affected by the solid stress
dynamics.
Shear Stress
The metastatic process subjects tumor cells to a variety of
additional microenvironments and forces. As tumor cells escape
the primary tumor and transit through the circulation, they are
exposed to a number of different solid and fluid forces, many of
which elicit shear stress (Figure 3). Hemodynamic shear stress,
which is caused by the movement of blood along the cell surface,
is influenced by both the fluid viscosity and fluid flow velocities
(Wirtz et al., 2011). Shear stress can also be caused by solid
forces from endothelial cell contact as tumor cells intravasate and
extravasate from the vasculature.
For metastasis to occur, tumor cells must survive transit
within the circulation, and not surprisingly, tumor cells have
been shown to be more resistant to shear stress than normal
cells (Mitchell et al., 2015). Survival is dependent on the time
spent in circulation and the magnitude of shear stress tumor
cells experience (Fan et al., 2016). Physiological resting levels of
shear stress [∼5–30 dynes/cm2 (0.5–3 Pa)] inhibit proliferation
and stimulate migration and adhesion of tumor cells (Avvisato
et al., 2007; Mitchell and King, 2013; Ma et al., 2017; Xiong
et al., 2017), while levels of shear stress similar to exercise
conditions [60 dynes/cm2 (6 Pa)] caused tumor cell death (Regmi
et al., 2017). Thus, the ability of a tumor cell to withstand the
various dynamic mechanical stresses it will encounter, as it leaves
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FIGURE 3 | Diverse mechanical stimuli act on tumor cells throughout cancer progression. Simplified depiction of oncogenic transformation and solid tumor
progression for cancers of epithelial origin (top). Letters indicate the stages of cancer progression focused on in panels (A–D). (A) In homeostatic tissues, the forces
between cells and the ECM are balanced. (B) The tumor microenvironment is composed of cancer cells with augmented contractility (increased intracellular tension),
surrounded by a progressively stiffening ECM (increased ECM resistance), and a host of stromal cell types including fibroblasts, immune cells and vascular cell types.
(C) Tumor expansion confined by the surrounding stroma compresses both the tumor and the adjacent stromal tissue, causing increased interstitial pressure.
Augmented ECM rigidity increases stromal resistance to compression and exacerbates solid stress. (D) A high interstitial fluid pressure gradient elicits fluid flow from
the tumor core to the periphery, promoting metastatic dissemination. Following escape from the primary tumor, cancer cells migrate along tension-oriented collagen
fibers toward the vasculature. Tumor cells are exposed to high shear stresses as they intravasate/extravasate between endothelial cells and travel through the
circulation en route to future secondary tumor sites.
the primary tumor and establishes a secondary tumor site, will
require continuous cellular adaptation.
Metastatic sites are not random. Primary tumors from
various organs show a preference for colonization of different
secondary organs, likely due to a combination of blood
flow pattern (mechanical hypothesis) and favorability of the
microenvironment (seed and soil hypothesis) (Wirtz et al., 2011).
Circulating tumor cell adhesion to the vessel wall is required for
extravasation. High shear stress increases the frequency of tumor-
endothelial cell contact, but impedes the ability of these cells to
form stable cell–cell adhesions (Wirtz et al., 2011). High shear
forces require tumor cells to make stronger adhesions in order to
extravasate. Thus, often tumor cells extravasate at branch points
or after being trapped in small capillaries (Wirtz et al., 2011).
Similar to how cells undergo drastic rearrangement of their
cytoskeleton and deformation to squeeze themselves through
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dense ECMmatrices (Wirtz et al., 2011), actomyosin contraction
induced cellular tension likely plays a vital role in tumor cell
resistance to shear forces, enabling survival in circulation and
during extravasation between endothelial cells. Importantly,
hemodynamic forces also affect the phenotype and function of
endothelial cells composing the vasculature and thus impact
cancer progression via this axis; however, this discussion is
outside the scope of this review.
Interstitial Fluid Pressure
In normal tissue, the interstitial fluid pressure is a physiological
hydrostatic pressure composed of the pressure from both
the free fluid and the fluid immobilized by hyaluronan.
However, the interstitial fluid pressure within the tumor
microenvironment drastically increases as a consequence of
tumor growth, augmented vascular permeability (leakiness) and
impaired lymphatic drainage (Stylianopoulos et al., 2013; Jain
et al., 2014).
Tumour blood vessels are often tortuous with irregular
branching morphologies and leaky due to a lack of pericyte
coverage (reviewed in Carmeliet and Jain, 2011). These vascular
abnormalities lead to inadequate blood flow rates, reduced
oxygen tension (hypoxia) and increased interstitial fluid pressure
(Carmeliet and Jain, 2011; Jain et al., 2014). Hyaluronan swelling
(due to increasing fluid retention), is another major contributor
to interstitial fluid pressure that can also intensify solid stress by
providing compressive resistance to the ECM (Jain et al., 2014).
Increasing solid stresses can lead to lymphatic vessel crushing
and impaired fluid drainage (Padera et al., 2004). Together, these
factors increase the interstitial fluid pressure within the tumor
and contribute to a difference in fluid pressures between the
tumor and the surrounding tissue (Jain et al., 2014).
The difference between the elevated interstitial fluid pressure
within the tumor and interstitial pressure of the adjacent
peritumoral tissue creates a fluid pressure gradient that causes
the outward flow of fluid from the tumor into the surrounding
stroma and may facilitate tumor cell escape from the primary
tumor (Figure 3; Jain et al., 2007). Furthermore, while solid
stresses impede blood flow and thereby inhibit perfusion,
high interstitial fluid pressure limits the penetration and
dissemination of therapeutic agents in solid tumors, impairing
treatment efficacy (Boucher and Jain, 1992; Jain et al., 2007, 2014).
ECM MATERIAL PROPERTIES
Cancer progression is associated with changes to tissue
structure and mechanical properties of the ECM (Figure 3).
Increased ECM rigidity (decreased compliance) correlates with
cancer progression and is sufficient to perturb normal tissue
morphology (Paszek et al., 2005).
ECM remodeling in the tumor involves ongoing production
of matrix proteins, their assembly and crosslinking, as well as
their turnover by MMPs. This remodeling contributes to ECM
stiffening, which occurs primarily through increased collagen
deposition (i.e., increased protein concentration), augmented
collagen crosslinking (e.g., higher lysyl oxidase (LOX) enzyme
expression), and via parallel reorientation of the collagen
fibers (Butcher et al., 2009; Kumar and Weaver, 2009; Yu
et al., 2011). Importantly, increased collagen abundance and
reorganization into thick, linearly oriented fibers correlates with
tumor progression and clinical outcome (Acerbi et al., 2015).
High ECM stiffness may also predispose individuals to develop
certain cancers. Normal breast tissue clinically determined to
have high mammographic density (MD) contains stiffer ECM,
thicker collagen fibers andmore linearized collagen than lowMD
breast tissue (Acerbi et al., 2015), and was shown to increase the
overall lifetime risk of breast cancer development (Boyd et al.,
1992; Razzaghi et al., 2012).
In the tumor microenvironment, collagen crosslinking
enhances integrin activation, focal adhesion maturation,
PI3K/AKT signaling and tumor cell invasion/metastasis
(Levental et al., 2009; Pickup et al., 2013; Rubashkin et al.,
2014). High LOX expression in mammary tumors drives
ECM stiffening, focal adhesion formation and metastasis,
which can be abrogated using a LOX inhibitor (Levental et al.,
2009; Pickup et al., 2013). Mechanistically, focal adhesion
stabilization by vinculin in response to rigid ECM stimulates
the activation of PI3K/AKT signaling and promotes tumor
cell proliferation and invasion (Levental et al., 2009; Pickup
et al., 2013; Rubashkin et al., 2014). Substrate rigidity-induced
actomyosin contractility, also increases invadopodia formation
and matrix degradation (Aung et al., 2014; Jerrell and Parekh,
2014), cellular responses associated with tumor aggression.
In addition to a rigid matrix, integrin clustering can be
facilitated by a bulky glycocalyx at the cell surface, which
applies tension to matrix-bound integrins (Paszek et al.,
2014). Hence, ECM stiffening through collagen crosslinking
stimulates tumor cells to generate higher intracellular tension
and exert stronger traction forces on their surroundings, which
subsequently increases ECM stiffness as a result of applied
tension. This positive feedback promotes tumor progression and
metastasis.
Tumor progression propagated by ECM rigidity involves
altered micro-RNA (miR) expression. Upregulation of oncogenic
miR-18a in response to integrin signaling was shown to
decrease PTEN expression and promote malignancy, in breast
cancer models (Mouw et al., 2014). Similarly, increased ECM
stiffness downregulates tumor suppressive miRs, such as miR-
203. Downregulation of miR-203 was shown to repress ROBO1,
which regulates actin organization and epithelial contraction (Le
et al., 2016).
At the tumor periphery, increased ECM tension promotes
remodeling that favors linear reorientation of collagen fibers.
This ECM organization, along with compression-induced solid
stress and a larger interstitial fluid pressure gradient (resulting
in increased fluid flow), may promote tumor cell escape from
the primary tumor. While cell migration through the ECM is
impeded by protein density (small pore size) (Wirtz et al., 2011),
metastasis is facilitated by oriented collagen fibers and paracrine
signals from immune cells that guide the directional migration of
tumor cells toward the vasculature (Condeelis and Pollard, 2006;
Leung et al., 2017). Accordingly, ECM stiffening and tumor grade
are associated with increase immune cell infiltration (Acerbi et al.,
2015).
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Remodeling of the ECM can cause the release and activation
of growth factors (e.g., TGF-beta) in the stroma which further
potentiate tumor progression. Matrix stiffness and TGF-beta can
both drive EMT and promote tumor metastasis by increasing
MMP secretion and cell migration (Wei et al., 2015). Likewise,
increased ECM stiffness and TGF-beta release also cause
fibroblast-to-myofibroblast conversion. Tumor associated
myofibroblasts display stronger actomyosin contractility
than their resident fibroblast precursors and exacerbate the
desmoplastic stromal response by secreting and remodeling
ECM proteins (Kumar and Weaver, 2009). Infiltrating immune
cells also contribute to the desmoplastic response by secreting
a variety of cytokines that activate the surrounding tumor and
stromal cells. Intriguingly, tumor-activated macrophages are
more compliant than resting macrophages (Yu et al., 2011).
Tumor-associated vasculature displays heightened
actomyosin contractility (Yu et al., 2011) and endothelial
cells plated on different ECM substrates have different responses
to tension (Collins et al., 2014). As increased cell-ECM tension
can disrupt cell–cell adhesions, augmented ECM stiffness
and changes to the ECM composition may promote hyper-
permeability of the already leaky blood vasculature and further
impair tissue drainage by the lymphatic vasculature.
POTENTIAL THERAPEUTIC TARGETING
In order to save lives, novel approaches to cancer prevention
and treatment are needed. Given the wealth of evidence
supporting physical forces as drivers of tumor growth and
metastasis, and the differences in the mechanical properties
of cells and matrix components between normal tissue and
cancer tissue, it is reasonable to target the mechanical features
of tumors for therapeutic intervention. This could be achieved
through modulation of the mechanical properties of the stroma
or inhibition of the cellular responses to increased stromal
stiffening. Discussed next are prospective cancer therapeutics
that target ECM stiffness, cell contractility or solid stress.
Inhibition of Cell Contractility
Targeting cell tension, by using drugs that inhibit signaling
downstream of focal adhesions to reduce actomyosin
contractility, has shown promise in blocking tumor progression.
In genetic mouse models of pancreatic cancer, treatment with
ruxolitinib, an inhibitor of JAK, significantly reduced STAT3
activity, collagen fibrillogenesis, and ECM stiffening (Laklai
et al., 2016). While ruxolitinib has been FDA approved for the
treatment of myeloproliferative neoplasms (reviewed in Santos
and Verstovsek, 2012), a phase 2 clinical trial of ruxolitinib
demonstrated little efficacy in the treatment of human pancreatic
tumors (Hurwitz et al., 2015). Several clinical trials of ruxolitinib
in breast cancer and leukemia are currently under way (https://
clinicaltrials.gov/).
Treatment of mice bearing patient-derived pancreatic tumors
with a ROCK inhibitor (Fasudil) enhanced the effectiveness
of standard chemotherapies (Gemcitabine/Abraxane) (Vennin
et al., 2017). Pre-clinical studies with a FAK inhibitor (VS-
4718) in a PDAC mouse model demonstrated diminished tumor
fibrosis, inhibited tumor progression, increased effectiveness of
chemotherapy (Gemcitabine), and an augmented responsiveness
to immunotherapy (αPD1) attributed to higher levels of
infiltrating CD8+ cytotoxic T lymphocytes (Jiang et al., 2016).
These studies show the promise of enhanced therapeutic
efficacy when combining drugs that target cell contractility with
chemotherapy and immunotherapies. FAK inhibition is also
being tested in clinical trials as a therapeutic strategy to inhibit
cell contractility in various types of solid tumors (reviewed in
Golubovskaya, 2014). To date, ten clinical trials aimed at testing
various FAK inhibitors (PF-00562271, Defactinib/VS-6063/PF-
04554878, VS-4718, GSK-2256098) in cancer patients have been
completed; however, the study results are pending for all but the
first phase 1 trial which assessed the safety and tolerability of
PF-00562271 (https://clinicaltrials.gov/ct2/show/NCT00666926)
(Infante et al., 2012).
Interestingly, retinoic acid treatment of pancreatic (PDAC)
tumors also decrease cell tension in response to strain
(Chronopoulos et al., 2016), suggesting that this pathway
may be of therapeutic utility. Alternatively, molecular mediators
of invadopodia formation could also be targeted in order to
reduce metastatic spread. Furthermore, given their newfound
involvement in cancer, mechanically-activated ion channels
(such as Piezo1) are also potential therapeutic targets.
However, some caution is needed as some side effects of
the chemotherapeutic drug cisplatin, have been attributed to
its non-specific inhibition of mechanosensitive ion channels
(Milosavljevic et al., 2010).
Targeting Solid Stress and Interstitial Fluid
Pressure
Solid stress compresses the vasculature and leads to hypoxia,
impaired drug delivery, and higher interstitial fluid pressure.
Thus, approaches have been developed to target solid and fluid
stresses within the tumor microenvironment. Examples include
hyaluronidases and angiotensin inhibitors. Hyaluronidases (e.g.,
PEGPH20), degrade the ECM protein hyaluronan to release
immobilized fluid and improve tissue compliance (Whatcott
et al., 2011). Angiotensin inhibitors (e.g., losartan) cause
dilation of the vasculature and blood pressure reduction,
thereby decreasing interstitial fluid pressure and enabling better
perfusion and therapeutic efficacy. In breast and pancreatic
cancers, inhibiting angiotensin with losartan decompressed
tumor blood vessels and reduced stromal collagen, which
increased vascular perfusion and improved drug delivery
(Chauhan et al., 2013). Furthermore, losartan was shown to
inhibit mammary tumor development and progression, as
well as increase in blood vessel diameter, by inhibiting AT1R
activation (Coulson et al., 2017). Both PEGPH20 and losartan
are currently in clinical trials for the treatment of solid tumors
(https://clinicaltrials.gov/) (results of completed studies were not
available at time of publication).
Modulation of ECM Stiffness
The desmoplastic stromal response is common to several types
of solid tumors, including pancreatic and breast cancers, and
is a major impediment to treatment as it increases tissue
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FIGURE 4 | Relationships between mechanical stress and tissue responses
during tumor progression to metastasis. Increased intracellular tension is
produced through actomyosin contraction in response to both biochemical
and mechanical stimuli. ECM stiffening stimulates cells to generate higher
intracellular tension to exert stronger traction forces on their surroundings,
which subsequently exacerbates ECM stiffness. Solid stress is caused in part
by unchecked proliferation of cancer cells that results in expansion of the
tumor mass, compression of the tumor interior and distention of the
surrounding stromal tissue. ECM stiffness can increase solid stress by
augmenting the resistance to tumor expansion. Reciprocally, tumor expansion
causes circumferential ECM tension and tissue stiffening. As a result of tissue
compression and ECM stiffening, blood and lymphatic vascular function is
impaired (due to vascular crushing) and interstitial fluid pressure is increased.
Aberrant fluid flow throughout the interstitial spaces and within the obstructed
tumor vasculature increases the shear stress experienced by tumor cells.
stresses and impairs drug delivery. Increased collagen deposition
by stromal fibroblasts largely contributes to the fibrosis in
the tumor microenvironment. Several drugs have emerged as
potent stromal inhibitors. In a mouse model of breast cancer,
targeting COX-2 with celecoxib significantly reduced αSMA-
positive cancer-associated fibroblasts, inhibited immune cell
recruitment and decreased collagen deposition, tumor growth
and metastasis (Esbona et al., 2016). Celecoxib (Celebrex), which
is clinically approved to treat inflammatory diseases, has been
clinically demonstrated to improve cancer treatment outcomes
but can cause serious adverse cardiovascular events, potentially
reducing its utility as an anti-cancer agent (reviewed in Chen
et al., 2014). Inhibitors of TGF-beta and hedgehog signaling (in
combination with standard chemotherapy) are also attractive
therapeutic targets to prevent desmoplasia, solid stress and tumor
progression (Ko et al., 2016, reviewed in Neuzillet et al., 2015).
Disruption of ECM stiffening using LOX inhibition, (e.g.,
BAPN) is a potential therapeutic strategy that has been shown
to greatly reduce tumor aggression in pre-clinical models of
breast cancer (Levental et al., 2009; Pickup et al., 2013; Mouw
et al., 2014). Another approach to targeting ECM remodeling is
inhibition of matrix metalloproteinase; however, these inhibitors
have shown little clinical promise (reviewed in Coussens et al.,
2002). Lastly, given the recent success of immunotherapies in the
treatment of cancer and the association between ECM stiffness,
immune cell infiltration and tumor grade (Acerbi et al., 2015), it
is conceivable that drugs which inhibit immune cell infiltration or
modulate immune cell responses (e.g., simvastatin, metformin)
may also improve cancer outcomes (Incio et al., 2015).
A potential limitation to all of these approaches is the high
variability in tumor phenotype between tumors, and even within
the same tumor, which could reduce therapeutic effectiveness.
This is exemplified by heterogeneity in cellular response to
stiffness between GBM tumors of same type (Grundy et al., 2016),
likely owing to underlying genetic variability. Nevertheless, these
approaches hold much promise for the treatment of cancers and
the most effective therapeutic strategies will probably impact
multiple sources of stress within the tumor microenvironment.
SUMMARY
Within the tumor microenvironment, tumor cells are exposed
to a number of different mechanical stimuli including cell–cell
and cell-ECM tension, compression stress from the expanding
tumor mass, interstitial fluid pressure, and shear stress.
Furthermore, positive feedback exists between these stimuli
and the responses they elicit (Figure 4), such as increased
cellular actomyosin contractility and ECM stiffening, which
exacerbates tumor progression and aggression. While this
review focused on solid tumors, these physical interactions
are universally applicable to all types of malignancies.
Thus, understanding the physical interactions between
components of the tumor microenvironment and the molecular
mechanisms regulating cellular responses to mechanical inputs
will be key to developing effective therapeutics to treat all
cancers.
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